IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q4 2022 Holdings

Filed 2023-02-14 | 5 holdings | $235.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$140.4M19,363,97559.7%
Pliant Therapeutics, Inc.(PLRX)COM729139105$41.2M2,132,86717.5%
Revolution Medicines, Inc.(RVMD)COM76155X100$33.8M1,419,90014.4%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$17.1M2,343,1547.3%
Magenta Therapeutics, Inc.COM55910K108$2.7M6,758,2041.1%